Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study
Oncology Research · 2023
DOI: 10.32604/or.2023.030351 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Oncology Research, 2023. Verfasst von Sukran Senyurek und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Koc University School of Medicine, Istanbul, 34450, Türkiye. Hauptthemen laut MEDLINE: Quality of Life, Rectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Koc University School of Medicine, Istanbul, 34450, Türkiye.
- Department of Medical Oncology, Demiroglu Bilim University Faculty of Medicine, Istanbul, 34394, Türkiye.
- Department of Radiation Oncology, Istanbul University Oncology Institute, Istanbul, 34093, Türkiye.
- Department of General Surgery, Istanbul University Istanbul Faculty of Medicine, Istanbul, 34093, Türkiye.
- Department of Medical Oncology, Istanbul University Oncology Institute, Istanbul, 34093, Türkiye.
- Department of Medical Physics, Istanbul University Oncology Institute, Istanbul, 34093, Türkiye.
Zitieren
APA
Senyurek, S., Saglam, S., Saglam, E. K., Yanar, H., Gok, K., Tastekin, D., Akbas, C. K., Sakin, N. D., Kartal, G. D., Balik, E., Keskin, M., Sanli, Y., Gulluoglu, M., & Akgun, Z. (2023). Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study. Oncology Research. https://doi.org/10.32604/or.2023.030351
Vancouver
Senyurek S, Saglam S, Saglam EK, Yanar H, Gok K, Tastekin D, et al. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study. Oncology Research. 2023. doi:10.32604/or.2023.030351
BibTeX
@article{Senyurek2023,
author = {Senyurek, Sukran and Saglam, Sezer and Saglam, Esra Kaytan and Yanar, Hakan and Gok, Kaan and Tastekin, Didem and Akbas, Canan Koksal and Sakin, Nergiz Dagoglu and Kartal, Gulbiz Dagoglu and Balik, Emre and Keskin, Metin and Sanli, Yasemin and Gulluoglu, Mine and Akgun, Zuleyha},
title = {Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study},
journal = {Oncology Research},
year = {2023},
doi = {10.32604/or.2023.030351}
}
EUVIMED